文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.

作者信息

Caprilli R, Gassull M A, Escher J C, Moser G, Munkholm P, Forbes A, Hommes D W, Lochs H, Angelucci E, Cocco A, Vucelic B, Hildebrand H, Kolacek S, Riis L, Lukas M, de Franchis R, Hamilton M, Jantschek G, Michetti P, O'Morain C, Anwar M M, Freitas J L, Mouzas I A, Baert F, Mitchell R, Hawkey C J

机构信息

John Radcliffe Hospital, Oxford OX3 9DU, UK.

出版信息

Gut. 2006 Mar;55 Suppl 1(Suppl 1):i36-58. doi: 10.1136/gut.2005.081950c.

DOI:10.1136/gut.2005.081950c
PMID:16481630
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1859996/
Abstract

This third section of the European Crohn's and Colitis Organisation (ECCO) Consensus on the management of Crohn's disease concerns postoperative recurrence, fistulating disease, paediatrics, pregnancy, psychosomatics, extraintestinal manifestations, and alternative therapy. The first section on definitions and diagnosis reports on the aims and methods of the consensus, as well as sections on diagnosis, pathology, and classification of Crohn's disease. The second section on current management addresses treatment of active disease, maintenance of medically induced remission, and surgery of Crohn's disease.

摘要

相似文献

[1]
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.

Gut. 2006-3

[2]
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations.

J Crohns Colitis. 2010-2

[3]
European evidence based consensus on the diagnosis and management of Crohn's disease: current management.

Gut. 2006-3

[4]
European Crohn's and Colitis Organisation Topical Review on Treatment Withdrawal ['Exit Strategies'] in Inflammatory Bowel Disease.

J Crohns Colitis. 2018-1-5

[5]
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management.

J Crohns Colitis. 2016-9-22

[6]
Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.

Dan Med Bull. 2011-12

[7]
Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.

Dig Liver Dis. 2005-6

[8]
Prevention of postoperative recurrence in Crohn's disease.

Clin Gastroenterol Hepatol. 2008-6

[9]
Management of inflammatory bowel disease.

Am Fam Physician. 1998-1-1

[10]
[Postoperative recurrence in Crohn's disease].

Chir Ital. 1995

引用本文的文献

[1]
Current practice and innovations in diagnosing perianal fistulizing Crohn's disease (pfCD): a narrative review.

Tech Coloproctol. 2025-4-15

[2]
Vaginal delivery in women with perianal Crohn's disease: why not?

AJOG Glob Rep. 2024-3-14

[3]
Optimising surgical anastomosis in ileocolic resection for Crohn's disease with respect to recurrence and functionality: two international parallel randomized controlled trials comparing handsewn (END-to-end or Kono-S) to stapled anastomosis (HAND2END and the End2End STUDIES).

BMC Surg. 2024-2-26

[4]
The mode of delivery does not influence the occurrence of post-partum perianal disease flares in patients with inflammatory bowel disease.

BMC Gastroenterol. 2024-1-16

[5]
Location-based prediction model for Crohn's disease regarding a novel serological marker, anti-chitinase 3-like 1 autoantibodies.

World J Gastroenterol. 2023-11-14

[6]
New pattern of individualized management of chronic diseases: focusing on inflammatory bowel diseases and looking to the future.

Front Med (Lausanne). 2023-5-10

[7]
Erythema Nodosum following Infection: A Case Report.

Medicina (Kaunas). 2022-12-19

[8]
It is not NOD2 - genetic and clinical risk factors for postoperative complications following ileocolic resection in Crohn's disease.

Int J Colorectal Dis. 2022-8

[9]
A Novel Clinical Radiomics Nomogram to Identify Crohn's Disease from Intestinal Tuberculosis.

J Inflamm Res. 2021-12-3

[10]
Review of pregnancy in Crohn's disease and ulcerative colitis.

Therap Adv Gastroenterol. 2021-5-18

本文引用的文献

[1]
Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial.

Gut. 2006-4

[2]
Inflammatory bowel disease in children and adolescents: recommendations for diagnosis--the Porto criteria.

J Pediatr Gastroenterol Nutr. 2005-7

[3]
A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis.

Health Technol Assess. 2005-6

[4]
Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn's disease.

Gastroenterology. 2005-4

[5]
Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trial.

Gastroenterology. 2005-4

[6]
Amount of systemic steroid medication is a strong predictor for the use of complementary and alternative medicine in patients with inflammatory bowel disease: results from a German national survey.

Inflamm Bowel Dis. 2005-3

[7]
Pharmacotherapy of osteoporosis in men.

Expert Opin Pharmacother. 2005-1

[8]
Sclerosing cholangitis.

Curr Opin Gastroenterol. 2004-5

[9]
MRI abnormalities of sacroiliac joints in early spondylarthropathy: a 1-year follow-up study.

Scand J Rheumatol. 2004

[10]
Ursodeoxycholic acid treatment in IBD-patients with colorectal dysplasia and/or DNA-aneuploidy: a prospective, double-blind, randomized controlled pilot study.

Anticancer Res. 2004

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索